Follow us...

 

Search News Archives

News Channels

 

Coronavirus (COVID-19)

 

View Channel

New Laboratory Products

 

View Channel

Lab News

 

View Channel

Research & Case Studies

 

View Channel

Microscopy | Image Analysis

 

View Channel

Separation Science

 

View Channel

Videos

 

View Channel

Events | Webinars

 

View Channel

Conferences | Events

Novozymes Biopharma offers opportunity to experience the benefits of award-winning sodium hyaluronate with free evaluation samples

publication date: Jul 7, 2010
 | 
author/source: The Scott Partnership

Novozymes Biopharma offers opportunity to experience the benefits of award-winning sodium hyaluronate with free evaluation samplesNovozymes Biopharma, part of Novozymes, world leader in bioinnovation, is offering customers free evaluation samples of the company's award-winning Bacillus-based sodium hyaluronate. The sample program precedes the 2011 launch of Novozymes Biopharma's new cGMP facility in Tianjin, China and will provide a unique opportunity to experience first-hand the quality of the product that will be manufactured at the cGMP Q7 validated site. The samples are available to all companies interested in evaluating the cGMP Q7 product and can be applied for via www.novozymeshasample.com

Novozymes Biopharma's sodium hyaluronate is 100% free of animal-derived raw materials and organic solvent remnants. The product is fermented using a unique non-pathogenic and well documented production strain, Bacillus subtilis, offering the medical device and pharmaceutical industries a range of benefits including increased safety, purity, batch-to-batch consistency and stability in large scale. The company's sodium hyaluronate can be used in a wide range of applications in the pharmaceutical sector for improved drug delivery as well as in medical device application areas such as ophthalmology, dermatology, osteoarthritis, dermal fillers, adhesion prevention, coating and wound healing. 

"We are delighted to offer new and existing users the opportunity to pilot Novozymes Biopharma's innovative sodium hyaluronate", comments Hans Ole Klingenberg, Product Director at Novozymes Biopharma. We are developing our new cGMP facility in China to expand the use of sodium hyaluronate and to set a new bench-mark for quality and consistency. This sample program precedes the opening of our new facility and is a unique opportunity for customers to sample our product and experience its benefits in drug delivery and medical device applications." 

Samples are available for a limited time. To request a free sample please visit www.novozymeshasample.com 

Novozymes Biopharma's sodium hyaluronate was awarded the CPhI Gold Innovation Award for its innovative production process allowing for better safety and improved consistency.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 

 

 

Media Partners